Cleared Traditional

K213137 - INTDose

K213137 is an FDA 510(k) clearance for INTDose, manufactured by Carina Medical, LLC. The device is a Class 2 Radiology device with product code IYE cleared through the Traditional 510(k) pathway after a 228-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2022
Decision
228d
Days
Class 2
Risk

K213137 is an FDA 510(k) clearance for the INTDose. Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Carina Medical, LLC (Lexington, US). The FDA issued a Cleared decision on May 13, 2022 after a review of 228 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Carina Medical, LLC devices

FDA 510(k) Submission Details - K213137

510(k) Number K213137 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2021
Decision Date May 13, 2022
Days to Decision 228 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
121d slower than avg
Panel avg: 107d · This submission: 228d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYE Device Classification - Class 2, Special Controls

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 335
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K213137.
ARIA Radiation Therapy Management (v16.1 MR3)
K221408 · Varian Medical Systems, Inc. · Jun 2022
ARIA Radiation Therapy Management (v15.8), Eclipse Treatment Planning System (v15.8)
K221448 · Varian Medical Systems, Inc. · Jun 2022
TrueBeam, TrueBeam STx, Edge, VitalBeam
K213977 · Varian Medical Systems, Inc. · Jun 2022
VacuumCushions, FeetSupports, LEPS (Lower Extermities Positioning System), CouchStrips
K212909 · Macromedics BV · May 2022
Aurora-RT
K213526 · Magnettx Oncology Solutions , Ltd. · May 2022
ExacTrac Dynamic
K220338 · Brainlab AG · Apr 2022